Tag Archives: vrtx

Apple Supplier Among 3 Top Earnings Reports Tonight

After a busy morning of earnings, a slew of financial reports are after the close, including Apple (AAPL) supplier NXP Semiconductor (NXPI), Chinese search giant Baidu (BIDU) and cystic fibrosis drugmaker Vertex Pharmaceuticals (VRTX). NXP Semiconductor makes chips that are used in the Apple iPhone, helping to power the new Apple Pay service. But NXP serves other mobile customers, and is expanding its work with Chinese partners as part of a smart

Vertex Tumbles As Cystic Fibrosis Data Disappoints

Big-cap biotech Vertex Pharmaceuticals (VRTX) was down 4% in morning trading today after the results on its latest cystic fibrosis drug disappointed investors. Vertex reported data from a midstage study combining drug candidate VX-661 with the already-marketed ivacaftor, branded Kalydeco, in patients with cystic fibrosis caused by homozygous F508del mutation. As IBD reported in our roundup of upcoming clinical-trial news last week, Vertex’s other

Alexion Beats Q4 Estimates, Appoints New CEO

Big-cap biotech Alexion Pharmaceuticals (ALXN) beat Q4 estimates but reported lower than expected guidance Thursday as it announced a change of leadership. Vertex Pharmaceuticals (VRTX) and Celgene (CELG) also moved on new earnings reports. Alexion’s sales rose 36% over the year-earlier quarter to $599 million, more than $8 million ahead of analysts’ consensus. Profit excluding one-time items gained 49% to $1.30 a share, beating estimates by a